S100A1 Gene Therapy Preserves in Vivo Cardiac Function after Myocardial Infarction

Cohn, 1997, Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research, Circulation, 95, 766, 10.1161/01.CIR.95.4.766 2004 Kato, 1986, S100a0 (alpha alpha) protein: distribution in muscle tissues of various animals and purification from human pectoral muscle, J. Neurochem., 46, 1555, 10.1111/j.1471-4159.1986.tb01776.x Most, 2001, S100A1: a regulator of myocardial contractility, Proc. Natl. Acad. Sci. USA, 98, 13889, 10.1073/pnas.241393598 Most, 2003, Transgenic overexpression of the Ca2+ binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance, J. Biol. Chem., 278, 33809, 10.1074/jbc.M301788200 Most, 2005, Distinct subcellular location of the Ca2+ binding protein S100A1 differentially modulates Ca2+ cycling in ventricular rat cardiomyocytes, J. Cell Sci., 118, 421, 10.1242/jcs.01614 Most, 2003, Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2), J. Biol. Chem., 278, 48404, 10.1074/jbc.M308587200 Remppis, 1996, Altered expression of the Ca2+-binding protein S100A1 in human cardiomyopathy, Biochim. Biophys. Acta, 1313, 253, 10.1016/0167-4889(96)00097-3 Most, 2004, Cardiac adenoviral S100A1 gene delivery rescues failing myocardium, J. Clin. Invest., 114, 1550, 10.1172/JCI21454 Kettlewell, S., Most, P., Currie, S., Koch, W. J., Smith, G. L. (2005). S100A1 increases the gain of excitation–contraction coupling in isolated rabbit ventricular cardiomyocytes. J. Mol. Cell. Cardiol. (in press). Most, 2003, The C terminus (amino acids 75-94) and the linker region (amino acids 42-54) of the Ca2+-binding protein S100A1 differentially enhance sarcoplasmic Ca2+ release in murine skinned skeletal muscle fibers, J. Biol. Chem., 278, 26356, 10.1074/jbc.M303338200 Yamasaki, 2001, Titin–actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1, Biophys. J., 81, 2297, 10.1016/S0006-3495(01)75876-6 Du, 2002, Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice, Mol. Cell. Biol., 22, 2821, 10.1128/MCB.22.8.2821-2829.2002 Emani, 2003, Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate, Mol. Ther., 8, 306, 10.1016/S1525-0016(03)00149-7 Hajjar, 1998, Modulation of ventricular function through gene transfer in vivo, Proc. Natl. Acad. Sci. USA, 28, 5251, 10.1073/pnas.95.9.5251 Shah, 2001, In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction, Circulation, 6, 1311, 10.1161/01.CIR.103.9.1311 Maurice, 1999, Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery, J. Clin. Invest., 104, 21, 10.1172/JCI6026 Hata, 2004, Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization, J. Mol. Cell. Cardiol., 37, 11, 10.1016/j.yjmcc.2004.03.014 Rockman, 1991, Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy, Proc. Natl. Acad. Sci. USA, 88, 8277, 10.1073/pnas.88.18.8277 Chien, 1993, Transcriptional regulation during cardiac growth and development, Annu. Rev. Physiol., 55, 77, 10.1146/annurev.ph.55.030193.000453 Remppis, 2002, The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytes, Basic Res. Cardiol., 97, I56, 10.1007/s003950200031 Remppis, 2004, S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts, J. Gene Med., 6, 387, 10.1002/jgm.513 Anand, 2000, Ventricular remodeling without cellular contractile dysfunction, J. Card. Fail., 8, S401, 10.1054/jcaf.2002.129566 Gosselin, 1998, Correlation between cardiac remodeling, function, and myocardial contractility in rat hearts 5 weeks after myocardial infarction, Can. J. Physiol. Pharmacol., 76, 53, 10.1139/y97-175 Gaballa, 2002, Ventricular remodeling in heart failure, J. Card. Fail., 8, S476, 10.1054/jcaf.2002.129270 Rabinowitz, 2002, Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity, J. Virol., 76, 791, 10.1128/JVI.76.2.791-801.2002 Ciulla, 2004, Left ventricular remodeling after experimental myocardial cryoinjury in rats, J. Surg. Res., 116, 91, 10.1016/j.jss.2003.08.238 Zimmermann, 2002, Cardiac grafting of engineered heart tissue in syngenic rats, Circulation, 106, I151, 10.1161/01.cir.0000032876.55215.10 Haider, 2004, Myoblast transplantation for cardiac repair: a clinical perspective, Mol. Ther., 9, 14, 10.1016/j.ymthe.2003.10.009 Tsoporis, 2003, The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart, Mol. Cell. Biochem., 242, 27, 10.1023/A:1021148503861 Engelhard, 1999, Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice, Proc. Natl. Acad. Sci. USA, 96, 7059, 10.1073/pnas.96.12.7059 He, 1998, A simplified system for generating recombinant adenoviruses, Proc. Natl. Acad. Sci. USA, 95, 2509, 10.1073/pnas.95.5.2509 Huwer, 2000, Model of chronic systolic and diastolic dysfunction after cryothermia-induced myocardial necrosis in rats, Comp. Med., 50, 385 Cho, 1999, Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression, J. Biol. Chem., 274, 22251, 10.1074/jbc.274.32.22251 Zhou, 2004, Vascular endothelial growth factor activation of sterol regulatory element binding protein: a potential role in angiogenesis, Circ. Res., 95, 471, 10.1161/01.RES.0000139956.42923.4A